These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 38398883)

  • 1. Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.
    Włodarczyk M; Ciebiera M; Nowicka G; Łoziński T; Ali M; Al-Hendy A
    Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review.
    Kamal DAM; Salamt N; Zaid SSM; Mokhtar MH
    Molecules; 2021 May; 26(9):. PubMed ID: 34063635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green Tea and Benign Gynecologic Disorders: A New Trick for An Old Beverage?
    Hazimeh D; Massoud G; Parish M; Singh B; Segars J; Islam MS
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
    J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids.
    Al-Hendy A; Segars JH; Taylor HS; González F; Siblini H; Zamah M; Alkelani H; Singh B; Flores VA; Christman GM; Johnson JJ; Huang H; Zhang H
    BMJ Open; 2024 Jan; 14(1):e078989. PubMed ID: 38216200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
    Siblini H; Al-Hendy A; Segars J; González F; Taylor HS; Singh B; Flaminia A; Flores VA; Christman GM; Huang H; Johnson JJ; Zhang H
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
    Matsuzaki S; Darcha C
    Hum Reprod; 2014 Aug; 29(8):1677-87. PubMed ID: 24876174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of green tea on endometriosis.
    Chen X; Man GCW; Hung SW; Zhang T; Fung LWY; Cheung CW; Chung JPW; Li TC; Wang CC
    Crit Rev Food Sci Nutr; 2023; 63(18):3222-3235. PubMed ID: 34620005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural therapies assessment for the treatment of endometriosis.
    Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
    Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
    Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
    Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
    Yang L; Zhang W; Chopra S; Kaur D; Wang H; Li M; Chen P; Zhang W
    Curr Drug Targets; 2020; 21(11):1099-1104. PubMed ID: 32364072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study.
    Grandi G; Del Savio MC; Melotti C; Feliciello L; Facchinetti F
    Gynecol Endocrinol; 2022 Jan; 38(1):63-67. PubMed ID: 34658291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
    Negri A; Naponelli V; Rizzi F; Bettuzzi S
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.
    Kim HS; Quon MJ; Kim JA
    Redox Biol; 2014; 2():187-95. PubMed ID: 24494192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
    Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
    Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.
    Huang YJ; Wang KL; Chen HY; Chiang YF; Hsia SM
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33113766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epigenetic background of the most common non-oncologic gynecological diseases].
    Joó JG; Csatlós E; Brubel R; Bokor A; Karabélyos C; Rigó J
    Orv Hetil; 2014 Mar; 155(13):492-9. PubMed ID: 24659742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.